Page 133 - Merck Sharp News Today

KUALA LUMPUR, Oct 7 — Malaysia has signed a letter of undertaking to purchase the antiviral drug Molnupiravir, developed by Merck Sharp & Dohme, Health Minister Khairy Jamaluddin said. Through the agreement, the government agreed to procure 150,000 complete treatment packages (patient...

PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

KUALA LUMPUR, Oct 7 — Antiviral drug Molnupiravir, developed by Merck Sharp & Dohme will be used against Covid-19 patients who suffered from symptoms for more than five days and the ones in more critical condition (category three, four and five), Health Minister Khairy Jamaluddin said this...

(TBTCO) - More than 2 million USD will be provided to help Vietnam reduce maternal deaths among ethnic minority women under a freshly-signed project.

Australia will have access to an additional COVID-19 treatment following the Morrison Government’s deal to purchase 300,000 courses of the promising

The Australian government has secured access to 300,000 courses of the "promising" treatment for Covid-19 as the country continues to battle the third wave of the pandemic, Prime Minister Scott Morrison and Health Minister Greg Hunt ...

The new cases were detected through 364,265 additional tests

Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 ...

COVID-19 drug Molnupiravir is a new medication that is in the form of a capsule developed by Merck Sharp & Dohme and Ridgeback Biotherapeutics.

Australia is on track to receive 300,000 courses of an antiviral drug showing promising signs of drastically reducing COVID-19 deaths and hospitalisations.